WOLVERINE ASSET MANAGEMENT LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 20 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$8,555,000
+39.6%
9,998,0000.0%0.10%
+21.8%
Q2 2017$6,128,000
-26.3%
9,998,0000.0%0.08%
-39.5%
Q1 2017$8,319,000
-30.8%
9,998,000
-21.3%
0.13%
-16.8%
Q4 2016$12,027,000
-23.7%
12,698,000
+0.1%
0.16%
-34.0%
Q3 2016$15,765,000
+12.7%
12,688,0000.0%0.24%
+10.8%
Q2 2016$13,985,000
-26.9%
12,688,000
+0.0%
0.21%
-61.0%
Q1 2016$19,141,000
+2.7%
12,687,000
+0.7%
0.54%
+35.7%
Q4 2015$18,633,000
-4.8%
12,600,0000.0%0.40%
-13.2%
Q3 2015$19,576,000
-25.9%
12,600,0000.0%0.46%
-23.0%
Q2 2015$26,434,000
+4.6%
12,600,0000.0%0.60%
+19.0%
Q1 2015$25,282,000
+5.3%
12,600,0000.0%0.50%
+7.9%
Q4 2014$23,999,000
+22.2%
12,600,0000.0%0.47%
+13.9%
Q3 2014$19,643,000
+17.1%
12,600,0000.0%0.41%
+11.7%
Q2 2014$16,768,000
+33.2%
12,600,000
+1.6%
0.37%
+35.9%
Q1 2014$12,592,000
-4.1%
12,400,000
-0.8%
0.27%
+3.8%
Q4 2013$13,125,000
+27.1%
12,500,000
+8.7%
0.26%
+13.0%
Q3 2013$10,327,00011,500,0000.23%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 16,490,000$25,947,00012.49%
SILVERBACK ASSET MANAGEMENT LLC 14,500,000$22,711,0002.37%
TANG CAPITAL MANAGEMENT LLC 3,500,000$5,259,0001.94%
ARISTEIA CAPITAL, L.L.C. 11,932,000$18,727,0000.95%
WOLVERINE ASSET MANAGEMENT LLC 12,600,000$19,576,0000.46%
Polar Capital LLP 3,120,000$4,965,0000.10%
Tekla Capital Management LLC 1,485,000$2,336,0000.08%
MIZUHO SECURITIES USA LLC 194,000$305,0000.08%
PALISADE CAPITAL MANAGEMENT, LP 1,410,000$2,206,0000.06%
LAZARD ASSET MANAGEMENT LLC 11,010,000$17,375,0000.04%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders